Also listed on Bioq Pharma Incorporated, an earlier holder on the record. The recorded assignments below show how it moved.
Term ends no later than Jul 16, 2027 · Medium confidence
20-year base term ends Jun 25, 2027
In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.
Jun 25, 2007
Jul 16, 2027
Jul 24, 2012
This patent's term runs 21 days past its 20-year base term on prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. All three maintenance fees are recorded paid; no more fees are due. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jun 25, 2007, when application 11/823,084, the earliest non-provisional in its chain, was filed (this one was filed Jun 3, 2009) | Jun 25, 2027 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +21 days, USPTO patent term adjustment record | Jul 16, 2027 | High confidence |
| Terminal disclaimer cap | Disclaimer on file (approved), reference document not resolved | no cap applied, and none guessed | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | no later than Jul 16, 2027 | Medium confidence |
This family
| US 8,292,848 | Lapsed on the fee record Oct 2024 | Oct 2024 |
| Application 11/982,719 | Abandoned not computed | not computed |
| Application PCT/US2008/007945 | PCT application no patent term | no patent term |
| US 8,211,059 | Lapsed on the fee record Jul 2024 | Jul 2024 |
| US 8,226,609 | this patent no later than Jul 2027 | no later than Jul 2027 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jul 16, 2009 Reel 22984, frame 763 | Kriesel, Marshall S.; Thompson, Thomas N.; Kriesel, Joshua W. | Bioquiddity, Inc. | Assignment of Assignor's Interest |
| Jan 29, 2016 Reel 37654, frame 867 | Bioquiddity Incorporated | Bioq Pharma Incorporated | Change of Name |
| Aug 9, 2017 Reel 43507, frame 944 | Bioq Pharma Incorporated | Madryn Health Partners, LP | Security Interest |
| Jul 13, 2023 Reel 64273, frame 414 | Madryn Health Partners, LP | Madryn Fund Administration, LLC | Security Interest |
| Jun 25, 2026 Reel 75815, frame 221 | Madryn Fund Administration, LLC, a Secured Party Conducting a Public Secured Party Sale of Assets of Bioq Pharma Incorporated | Madryn Bioq SPV, LLC | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer is on file (approved) and its reference document is not resolved. A disclaimer would cap the term earlier than Jul 16, 2027. We will not guess the cap.